These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32833876)

  • 1. Thoughts About Schizophrenia 66 Years After Chlorpromazine.
    Meyer RE
    J Clin Psychopharmacol; 2020; 40(5):436-438. PubMed ID: 32833876
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative effectiveness of antipsychotic drugs. A commentary on: Cost Utility Of The Latest Antipsychotic Drugs In Schizophrenia Study (CUtLASS 1) and Clinical Antipsychotic Trials Of Intervention Effectiveness (CATIE).
    Lieberman JA
    Arch Gen Psychiatry; 2006 Oct; 63(10):1069-72. PubMed ID: 17015808
    [No Abstract]   [Full Text] [Related]  

  • 3. Hope lost and found.
    Shindler N
    Psychiatr Serv; 1998 Aug; 49(8):1023-4. PubMed ID: 9712206
    [No Abstract]   [Full Text] [Related]  

  • 4. Specific indications for different classes of phenothiazines.
    Hollister LE; Overall JE; Kimbell I; Pokorny A
    Arch Gen Psychiatry; 1974 Jan; 30(1):94-9. PubMed ID: 4148660
    [No Abstract]   [Full Text] [Related]  

  • 5. Personal reflections on diagnosis.
    Vonnegut M
    J Ment Health; 2010 Aug; 19(4):373-5. PubMed ID: 20636119
    [No Abstract]   [Full Text] [Related]  

  • 6. The efficacy and safety of clozapine versus chlorpromazine in geriatric schizophrenia.
    Howanitz E; Pardo M; Smelson DA; Engelhart C; Eisenstein N; Stern RG; Losonczy MF
    J Clin Psychiatry; 1999 Jan; 60(1):41-4. PubMed ID: 10074877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosage of conventional neuroleptic medication and subjective cognitive functioning in schizophrenia.
    Krausz M; Moritz S; Lambert M; Naber D
    Int Clin Psychopharmacol; 2000 Mar; 15(2):77-81. PubMed ID: 10759338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Late schizophrenia].
    Morishita S
    Ryoikibetsu Shokogun Shirizu; 2003; (38):80-3. PubMed ID: 12876935
    [No Abstract]   [Full Text] [Related]  

  • 9. Antipsychotic therapy over half a century: a tale of discovery from chlorpromazine to aripiprazole.
    Natesan S; Kapur S
    Natl Med J India; 2012; 25(4):193-5. PubMed ID: 23278774
    [No Abstract]   [Full Text] [Related]  

  • 10. Olanzapine compared with chlorpromazine in treatment-resistant schizophrenia.
    Conley RR; Tamminga CA; Bartko JJ; Richardson C; Peszke M; Lingle J; Hegerty J; Love R; Gounaris C; Zaremba S
    Am J Psychiatry; 1998 Jul; 155(7):914-20. PubMed ID: 9659857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. My father, my life, and chlorpromazine.
    Artigues MF
    N C Med J; 2000; 61(2):90-4. PubMed ID: 10737030
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of antipsychotic drugs on memory functions of schizophrenic patients.
    Eitan N; Levin Y; Ben-Artzi E; Levy A; Neumann M
    Acta Psychiatr Scand; 1992 Jan; 85(1):74-6. PubMed ID: 1347670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does the medication pattern reflect the CYP2D6 genotype in patients with diagnoses within the schizophrenic spectrum?
    Jürgens G; Rasmussen HB; Werge T; Dalhoff K; Nordentoft M; Andersen SE
    J Clin Psychopharmacol; 2012 Feb; 32(1):100-5. PubMed ID: 22198443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Akathisia: clinical phenomenology and relationship to tardive dyskinesia.
    Kahn EM; Munetz MR; Davies MA; Schulz SC
    Compr Psychiatry; 1992; 33(4):233-6. PubMed ID: 1353716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re: From chlorpromazine to clozapine--antipsychotic adverse effects and the clinician's dilemma.
    Nardi AE
    Can J Psychiatry; 2004 Nov; 49(11):784; author reply 784. PubMed ID: 15633857
    [No Abstract]   [Full Text] [Related]  

  • 16. Ideology and Scientific Progress: First-Rank Symptoms.
    Carpenter WT; Strauss JS
    Schizophr Bull; 2019 Sep; 45(5):950-951. PubMed ID: 31508803
    [No Abstract]   [Full Text] [Related]  

  • 17. Another view of the history of antipsychotic drug discovery and development.
    Carpenter WT; Davis JM
    Mol Psychiatry; 2012 Dec; 17(12):1168-73. PubMed ID: 22889923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurocognitive effects of first- and second-generation antipsychotic drugs in early-stage schizophrenia: a naturalistic 12-month follow-up study.
    Guo X; Zhai J; Wei Q; Twamley EW; Jin H; Fang M; Hu M; Zhao J;
    Neurosci Lett; 2011 Oct; 503(2):141-6. PubMed ID: 21888948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conceptualizing schizophrenia through attenuated symptoms in the population.
    Carpenter WT
    Am J Psychiatry; 2010 Sep; 167(9):1013-6. PubMed ID: 20826849
    [No Abstract]   [Full Text] [Related]  

  • 20. Psychomotor impairment and cognitive disturbances induced by neuroleptics.
    King DJ
    Acta Psychiatr Scand Suppl; 1994; 380():53-8. PubMed ID: 7914050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.